Connect with us

Hi, what are you looking for?

Investing

Novavax’s stock soars 51% after positive COVID and flu trial data and layoff news

Novavax Inc.’s stock soared 51% Tuesday after the biotech company reported positive results from a trial of three flu and COVID vaccines and unveiled a restructuring that will see it part with a quarter of its staff.

The move put the stock on track for its biggest one-day gain in more than two years as worries raised by the company’s “going-concern” warning from earlier this year appeared to ease.

For…

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

This article was written by Follow Envision Research, aka Lucas Ma, has over 20+ years of investment experience and holds a Masters with in...

News

Follow Play Earnings CallPlay Earnings Call Riot Platforms, Inc. (RIOT) Discusses Transformational Milestones and Strategic Data Center Expansion January 16, 2026 10:00 AM EST...

News

This article was written by Follow Freelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various...